Cancer Therapeutics CRC (CTx) is dedicated to Finding Cures for Cancer. CTx is an oncology focused small molecule drug discovery and early development biotechnology group. We were established under the Australian government’s Cooperative Research Centre (CRC) initiative. Our unique collaboration model leverages the capabilities and expertise of its Industry Participants with those of a number of Australia’s pre-eminent Medical Research Institutes and Universities. CTx has successfully discovered, developed and commercialised small molecule cancer drugs to the global pharmaceutical market.
Looking for a particular Cancer Therapeutics CRC (CTx) employee's phone or email?
Cancer Therapeutics CRC (CTx) Questions
The Cancer Therapeutics CRC (CTx) annual revenue was $13 million in 2026.
Kurt Lackovic is the CEO of Cancer Therapeutics CRC (CTx).
1 people are employed at Cancer Therapeutics CRC (CTx).
Cancer Therapeutics CRC (CTx) is based in Melbourne, Victoria.
The NAICS codes for Cancer Therapeutics CRC (CTx) are [5417, 541, 54, 54171, 541713].
The SIC codes for Cancer Therapeutics CRC (CTx) are [873, 87].
Top Cancer Therapeutics CRC (CTx) Employees
